Ocular Therapeutix, Inc. (OCUL) by event type
OCUL moves most on analyst upgrades — a median of -1.88% at 30 minutes across 14 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the OCUL overview →
How OCUL reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,692 of 2,717 | 14 | -1.88% | 29% | -0.80% |
| Analyst downgrades 2,442 of 2,603 | 11 | -1.15% | 36% | -2.16% |
| Coverage initiations 2,174 of 2,283 | 21 | -1.46% | 24% | -4.04% |
| Rating reiterations 2,552 of 3,522 | 84 | -0.10% | 46% | -0.15% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how OCUL usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · OCUL overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AMPLIPHI BIOSCIENCES CORP (APHB) | 422 | -0.98% | 32% |
| Henry Schein, Inc. (HSIC) | 422 | -0.08% | 44% |
| ASTERIAS BIOTHERAPEUTICS INC (AST) | 416 | -0.53% | 34% |
| BIOPHARMX CORP (BPMX) | 416 | -1.58% | 28% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.